Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03836521 · ClinicalTrials.gov registry record
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
A clinical trial of Bicuspid Aortic Valve, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03836521: Recruiting study of Bicuspid Aortic Valve, sponsored by Cedars-Sinai Medical Center.
NCT03836521 is a study of Bicuspid Aortic Valve that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 2,000 participants, below the 2,350-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03836521, a study of Bicuspid Aortic Valve, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Primary Outcome
Death from any cause
Conditions Studied
Interventions
- DEVICE Transcatheter aortic valve replacement
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2016-08-15 |
| Est. Completion | 2028-08-15 |
What NCT03836521 shows while recruiting
NCT03836521 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,350-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Bicuspid Aortic Valve appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter aortic valve replacement is the first listed.
NCT03836521 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03836521 about?
NCT03836521 is a clinical study titled "Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry". The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
What is the current status of trial NCT03836521?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2016-08-15. Estimated completion is 2028-08-15.
What conditions does trial NCT03836521 study?
This clinical trial studies the following conditions: Bicuspid Aortic Valve.
What interventions are being tested in trial NCT03836521?
The interventions under investigation include: Transcatheter aortic valve replacement (DEVICE).
Who is sponsoring clinical trial NCT03836521?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03836521 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bicuspid Aortic Valve
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bicuspid Aortic Valve (BAV) Registry
RECRUITING
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
Identification of Genetic Causes of Bicuspid Aortic Valve Disease
ACTIVE NOT RECRUITING
-
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI